Skip to content

Computerised Intervention/Treatment for Adolescent Depression and Low Mood:

Computerised Intervention/Treatment for Adolescent Depression and Low Mood: Feasibility Phase 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02186730
Acronym
CITADAL
Enrollment
48
Registered
2014-07-10
Start date
2014-04-03
Completion date
2016-08-01
Last updated
2020-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Computerised Cognitive Behaviour Therapy, Adolescents, Depression, Low Mood

Brief summary

This study forms the second phase of previous work to examine the effectiveness of computerised Cognitive Behaviour Therapy (cCBT) to treat adolescents with low mood/depression. Depression affects around 2% of adolescents. Antidepressants are not recommended for this age range as a first line treatment because of concerns about their usefulness and side effects. Government guidelines have supported using Cognitive Behaviour Therapy (CBT), which is effective and one of the main treatments recommended for depression. It has been suggested that computerised versions of CBT (cCBT) may be effective for treating depression in young people who may prefer this to seeing a therapist face-to-face, but little research exists to date to support this. This study examines the feasibility of running a large scale randomised controlled trial (RCT) to compare a promising cCBT program (Stressbusters) with self-help websites for adolescents with low mood and depression (LMD). Eligible and consenting participants will complete several questionnaires to assess their mood before being randomly assigned to either cCBT (Stressbusters) or equivalent access to selected websites providing self help for LMD. Participants will complete further mood questionnaires 4 and 12 months after treatment completion/withdrawal. We have already recruited 97 individuals to this trial but aim to recruit a further 48 participants to collect further information. We are also keen to find out whether sending participants text messages before sessions and around follow up periods will increase attendance/completion. Therefore all trial participants will receive text messages from the research team during their participation.

Interventions

BEHAVIORALStressbusters

cCBT

BEHAVIORALWebsites

Self help websites

Sponsors

Leeds and York Partnership NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 12 to 18 years * Low mood/depression * co-morbid physical illness or co-morbid non-psychotic functional disorders, such as anxiety

Exclusion criteria

* Suicidality * Postnatally depressed * Suffering psychotic symptoms

Design outcomes

Primary

MeasureTime frame
Changes on the Short Beck Depression Inventory from baseline to 4 and 12 months follow upbaseline, 4 months follow up, 12 months follow up

Secondary

MeasureTime frame
Changes on the Spence Children's Anxiety Scale from baseline to 4 and 12 months follow upBaseline, 4 months follow up and 12 months follow up
Changes in health status measured by the EQ-5D-Y from baseline to 4 and 12 months follow upBaseline, 4 months follow up, 12 months follow up
Changes in health status measured by the HUI2 from baseline to 4 and 12 months follow upBaseline, 4 months follow up and 12 months follow up
The number of health services used by participants between baseline, 4 months and 12 months follow upBaseline, 4 months follow up, 12 months follow up
Changes on the Mood and Feelings Questionnaire from baseline to 4 and 12 months follow upBaseline, 4 months follow up, 12 months follow up
The Short Mood and Feelings Questionnaireup to 8 weeks

Other

MeasureTime frame
Number of inpatient admissions during trial participation12 months
Further mental health support received during trial participation12 months
Number of self-harm episodes during trial participation12 months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026